Detecting Cancer’s Methylation Fingerprint in Blood Plasma

Since 2012, Universal Diagnostics has been working to revolutionize early cancer detection. To make their high-throughput, NGS-based assay a reality, they needed a reputable, trustworthy source of custom panels for hybrid capture. They found the source they were looking for — as well as an enthusiastic research partner — in Twist Bioscience.

Covered in this Case Study

Learn how DNA circulating in the blood can be used to detect cancer with just a 9 ml sample

Learn how Methylation Patterns on circulating tumor DNA can uncover cancer early

Read about how Universal Diagnostics are using Twist Bioscience's NGS tools to detect cancer

Share your details to Get the Case Study

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Detecting Cancer’s Methylation Fingerprint in Blood Plasma

Related Resources

Twist Alliance Canine Exome - 40.5 Mb .bed file

Accurate CRC Detection by Targeted MethylSeq of ctDNA

SARS-CoV-2 Variants: How to "Capture" them